A consortium comprising Asia-focused private equity firm FountainVest Partners and China-based global investment firm Primavera Capital Group has acquired 24.78 per cent stake in Shanghai-listed LBX Pharmacy from EQT Greater China II Fund, according to a statement.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
